Alamar Biosciences Faces $45 M Insider Sell‑Off as Qiming Corporate GP VI Cuts Stakes by 10%+ in Sharp Oct. 19 Trade Dump.
Qiming Corporate GP VI’s $45M insider sale of 1.7M Alamar shares signals strategic rebalancing, not panic—watch for impact on biotech valuations.
4 minutes to read